Phase II Results of Ara-C and Idarubicin in Combination with the Selective Inhibitor of Nuclear Export (SINE) Compound Selinexor (KPT-330) in Patients with Relapsed or Refractory AML

被引：9

作者：

Fiedler, Walter ^{[1
]}

Heuser, Michael ^{[2
]}

Chromik, Joerg ^{[3
]}

Thol, Felicitas ^{[2
]}

Bokemeyer, Carsten ^{[4
]}

Theile, Susann ^{[5
]}

Lebkuechner, Isabell ^{[5
]}

Kranich, Anne L. ^{[6
]}

机构：

[1] Univ Hosp Eppendorf, Dept Hematol & Oncol, Hamburg, Germany

[2] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany

[3] Univ Hosp Frankfurt, Frankfurt, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Ctr Oncol, Med Clin & Polyclin 2, Hamburg, Germany

[5] GSOmbH, Hamburg, Germany

[6] GSO Global B V, Amsterdam, Netherlands

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.341.341

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

341

引用

页数：6

共 50 条

[21] A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas. [J].

Gounder, Mrinal M. ;

Loong, Herbert H. F. ;

Nyquist-Schultz, Kjirsten ;

Baker, Stephanie ;

Ustoyev, Yelena ;

Tanner, Lanier R. ;

Shacham, Sharon ;

McCauley, Dilara ;

Rashal, Tami ;

Saint-Martin, Jean-Richard ;

Shacham, Eran ;

Friedlander, Sharon ;

Tamir, Sharon ;

Marshall, Tracey ;

Landesman, Yosef ;

Kauffman, Michael ;

Rebello, Sasha ;

Mirza, Mansoor Slide Raza ;

Schwartz, Gary K. ;

Razak, Albiruni R. A. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[22] A phase 1 dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with heavily pretreated non-Hodgkin lymphoma (NHL). [J].

Gutierrez, Martin ;

Goy, Andre ;

Byrd, John C. ;

Flynn, Joseph M. ;

Sorensen, Morten ;

Brown, Peter ;

Gabrail, Nashat Y. ;

Savona, Michael ;

Flinn, Ian ;

Baz, Rachid C. ;

Shah, Bijal D. ;

Stone, Richard M. ;

Jacobsen, Eric ;

Kukreti, Vishal ;

Tiedemann, Roger E. ;

Rashal, Tami ;

Mirza, Mansoor Raza ;

Shacham, Sharon ;

Kauffman, Michael ;

Kuruvilla, John .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[23] A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma [J].

Cornell, R. Frank ;

Rossi, Adriana C. ;

Baz, Rachid ;

Hofmeister, Craig C. ;

Shustik, Chaim ;

Richter, Joshua R. ;

Chen, Christine ;

Vogl, Dan T. ;

Shacham, Sharon ;

Baloglu, Erkan ;

Senapedis, William ;

Ellis, Joel ;

Friedlander, Sharon ;

Choe-Juliak, Cassandra ;

Cubitt, Christopher L. ;

Turner, Joel G. ;

Sullivan, Daniel ;

Kauffman, Michael .

BLOOD, 2016, 128 (22)

[24] A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of unclear export (SINE) in patients (pis) with advanced solid tumors [J].

Mau-Soerensen, Morten ;

Razak, Albiruni R. A. ;

Shields, Anthony Frank ;

Gabrall, Nashat Y. ;

Gereeltano, John F. ;

Shacham, Sharon ;

Lassen, Ulrlk Niels ;

Rashal, Taml ;

Cooksoy, Jennifer ;

Landosman, Yosof ;

Pond, Gregory ;

Oza, Amit M. ;

Kauffman, Michael ;

Siu, Lillian L. ;

Bedard, Philippe L. ;

Mahaseth, Hemchandra ;

Mlrza, Mansoor Raza ;

Mahipal, Arnit .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[25] Preclinical and early clinical activity of the oral selective inhibitor of nuclear export (SINE) exportin I (XPOI) antagonist KPT-330 (Selinexor) in patients (pts) with platinum-resistant/refractory ovarian cancer (OvCa). [J].

Martignetti, John ;

Razak, Albiruni R. A. ;

Chen, Ying ;

Gabrail, Nashat Y. ;

Gerecitano, John F. ;

Camacho, Catalina ;

Pereira, Elena ;

Dottino, Peter Remsen ;

Shacham, Sharon ;

McCauley, Dilara ;

Rashal, Tami ;

Saint-Martin, Jean-Richard ;

Shacham, Eran ;

Vincett, Darcy ;

Kauffman, Michael ;

Mirza, Mansoor Raza ;

Sorensen, Morten .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[26] PRECLINICAL AND EARLY CLINICAL ACTIVITY OF THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) EXPORTIN 1 (XPO1) ANTAGONIST SELINEXOR (KPT-330) IN PATIENTS (PTS) WITH PLATINUM RESISTANT/REFRACTORY OVARIAN CANCER (OVCA) [J].

Martignetti, J. ;

Razak, A. R. A. ;

Chen, Y. ;

Gabrail, N. Y. ;

Gericitano, J. F. ;

Camacho, C. ;

Pereira, E. ;

Evans, B. ;

Dottino, P. ;

McCauley, D. ;

Shacham, S. ;

Rashal, T. ;

Saint-Martin, J. ;

Shacham, E. ;

Vincent, D. ;

Kauffman, M. ;

Mirza, M. R. ;

Mau-Sorensen, M. .

ANNALS OF ONCOLOGY, 2014, 25

[27] Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Of a First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin's Lyphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [J].

Kuruvilla, John ;

Gutierrez, Martin ;

Shah, Bijal D. ;

Gabrail, Nashat Y. ;

Brown, Peter de Nully ;

Stone, Richard M. ;

Garzon, Ramiro ;

Savona, Michael ;

Siegel, David S. ;

Baz, Rachid ;

Mau-Sorensen, Morten ;

Davids, Matthew S. ;

Byrd, John C. ;

Shacham, Sharon ;

Rashal, Tami ;

Yau, Cindy Y. F. ;

McCauley, Dilara ;

Saint-Martin, Jean-Richard ;

McCartney, John ;

Landesman, Yosef ;

Klebanov, Boris ;

Pond, Greg ;

Oza, Amit M. ;

Kauffman, Michael ;

Mirza, Mansoor R. .

BLOOD, 2013, 122 (21)

[28] TOPICAL SELINEXOR (KPT-330), A SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SHOWS INCREASED BLOOD FLOW AND ACCELERATED HEALING USING NONINVASIVE TECHNIQUES IN AN ISCHEMIC MODEL OF WOUND HEALING [J].

Ganesh, K. ;

Kitsos, C. ;

Rashal, T. ;

Roy, S. ;

Gnyawali, S. ;

Friedlander, S. ;

Chen, W. ;

Ellis, J. ;

Austad, B. ;

McCauley, D. ;

Kauffman, M. ;

Shacham, S. ;

Sen, C. .

WOUND REPAIR AND REGENERATION, 2015, 23 (02) :A22-A22

[29] THE ORAL SELECTIVE INHIBITOR OF NUCLEAR EXPORT (SINE) SELINEXOR (KPT-330) ACTIVITY IN DOUBLE HIT DIFFUSE LARGE B CELL LYMPHOMAS (DLBCL) IN PRECLINICAL MODELS & CLINICAL ACTIVITY IN PATIENTS WITH DLBCL [J].

Kuruvilla, J. ;

Cerchietti, L. ;

Wagner-Johnston, N. ;

Stone, R. ;

Jacobsen, E. ;

Mau-Sorensen, M. ;

Brown, P. ;

Baz, R. ;

Shal, B. ;

Flynn, J. ;

Flinn, I. ;

Kukreti, V. ;

Tiedemann, R. ;

Goy, A. ;

Landesman, Y. ;

Klebanov, B. ;

Shacham, E. ;

Saint-Martin, J. R. ;

Marshall, T. ;

McCartney, J. ;

McCauley, D. ;

Carlson, R. ;

Rebello, S. ;

Rashal, T. ;

Mirza, M. R. ;

Shacham, S. ;

Kauffman, M. ;

Gutierrez, M. .

HAEMATOLOGICA, 2014, 99 :152-152

[30] Nuclear export inhibitor selinexor (KPT-330) demonstrates anti-tumor efficacy alone and in combination with chemotherapy in multiple breast cancer models [J].

Arango, Natalia Paez ;

Evans, Kurt ;

Zhao, Ming ;

Yuca, Erkan ;

Scott, Stephen ;

Kim, Charissa ;

Naing, Aung ;

Meric-Bernstam, Funda .

CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →